The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
This webinar takes a deep look at industries that have evolved successful and meaningful supplier relationships to advance shared value among a…
On-Demand Educational Webinars
Tracking surgical supplies is a challenge. Average returns for picked supplies is low, O.R. in-and-out traffic to retrieve items is high, and…
On-Demand Educational Webinars
Although suppliers and providers may hesitate at a partnership approach, it is possible to collaborate on total cost of ownership. Learn from the…
On-Demand Educational Webinars
Social responsibility is an emerging area of importance for all health care supply chain professionals to understand and participate in. This webinar…
On-Demand Educational Webinars
In order to compare baseline costs to savings and determine areas of compliance risk, supply chain professionals need to work closely with their…